The Broad InstituteBoston, Massachusetts, United States
Disclosure information not submitted.
Paper 46 - GENOMIC FEATURES AND CIRCULATING TUMOR DNA IN PATIENTS WITH INTERMIDIATE RISK RHABDOMYOSARCOMA TREATED ON ARST1431 AN INTERIM REPORT FROM THE CHILDRENS ONCOLOGY GROUP
Friday, November 3, 20232:30 PM – 4:00 PM
Paper 65 - PRE-TREATMENT CTDNA BURDEN AND GENOMIC FEATURES ARE PROGNOSTIC AMONG PATIENTS WITH METASTATIC EWING SARCOMA TREATED ON AEWS1221: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP (COG)
Saturday, November 4, 202310:00 AM – 11:00 AM